Engineering of a Stable Retroviral Gene Delivery Vector by Directed Evolution
Open Access
- 1 February 2008
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 16 (2) , 308-314
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Nature Medicine, 2006
- State-of-the-art of the production of retroviral vectorsThe Journal of Gene Medicine, 2004
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Ligand-directed targeting of genes to the site of diseaseNature Medicine, 2003
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative ConditioningScience, 2002
- Breeding of retroviruses by DNA shuffling for improved stability and processing yieldsNature Biotechnology, 2000
- Gene therapy: trials and tribulationsNature Reviews Genetics, 2000
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Kinetics of retrovirus production and decayBiotechnology and Bioengineering, 1999
- Large-Scale Processing of Recombinant Retroviruses for Gene TherapyBiotechnology Progress, 1999